Autopsy report · NCT07517445
Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis
Cause of deathSafety
“A temporary precautionary pause in enrolment into all arms of the trial was implemented on 21 July 2026, due to emerging hepatic safety signal. A protocol amendment is currently underway.”
Life of this trial
- Suspended: paused, and may or may not restart.
- 165 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- Gates Medical Research Institute
- Sponsor type
- University, hospital or other
- Conditions
- Drug Susceptible Pulmonary Tuberculosis
- Interventions
- Bedaquiline, pretomanid, linezolid; Bedaquiline, pretomanid, linezolid; Bedaquiline, pretomanid, linezolid; Nicotinamide (NAM)
- Participants
- 165 (planned, not actual)
- Sites
- 4
- Countries
- South Africa
Trials that died the same way
- Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)
“Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns, specifically new emerging evidence of hepatic injury.” - A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension
“This trial was prematurely terminated on Dec 9 2010 due to safety concerns, specifically emerging evidence of hepatic injury.” - BreathID Multi-center HCV Liver Breath Test Study
“Due to FDA comments, protocol changed; new trial will be proposed shortly” - Pre-emptive Anakinra for Cytokine Event Reduction
“The trial has been stopped pending FDA approval of modifications to the trial protocol.” - Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
“The trial was stopped earlier than planned after an ad hoc interim analysis”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.